-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

501.P1.27 501. Hematopoietic Stem and Progenitor Biology: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
apoptosis, HSCs, Animal models, Diseases, platelets, Genetic Disorders, red blood cells, Biological Processes, white blood cells, Technology and Procedures, Cell Lineage, epigenetics, Study Population, hematopoiesis, flow cytometry, RNA sequencing, pathways
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Qingqing Wu, PhD1, Jizhou Zhang, M.D.1, Courtney Johnson, BS1*, Anastasiya Slaughter, BA1, Margot Lindsay May, BS1 and Daniel Lucas-Alcaraz, PhD1,2

1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Medical center, Cincinnati, OH
2Cincinnati Children's Hospital, Cincinnati,, OH

Zhe Chen, PhD1*, Lei Li2*, Jieping Chen2* and Yu Hou, PhD3

1Department of Hematology, Southwest Hospital, Third Military Medical University (Army Medical University), chongqing, China
2Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China
3Department of Hematology, Southwest Hospital, Third Military Medical University (Army Medical University), CHONGQING, China

Tessa Dignum, BS1*, Barbara Varnum-Finney, PhD1*, Sanjay Srivatsan2*, Stacey Dozono1*, Olivia Waltner1*, Adam Heck, PhD1*, Cynthia Nourigat-Mckay1*, Dana Jackson2*, Shahin Rafii, MD3, Irwin D. Bernstein, MD1, Cole Trapnell, PhD2* and Brandon Hadland, MD, PhD1

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Genome Sciences, University of Washington School of Medicine, Seattle, WA
3Department of Medicine, Ansary Stem Cell Institute, Weill Cornell Medicine, New York, NY

Leonardo Rivadeneyra, PhD1*, Melissa M. Lee-Sundlov, PhD1, Simon Glabere1*, Heather Ashwood1*, Robert Burns, PhD1* and Karin M. Hoffmeister, MD1,2

1Translational Glycomics Center, Versiti Blood Research Institute, Milwaukee, WI
2Departments of Medicine and Biochemistry, Medical College of Wisconsin, Milwaukee, WI

Chen Wang, MD1,2, Weinan Wang, BS2*, Lei Huang, PhD1,2*, Yoshihiro Hayashi, MD, PhD2, Xiongwei Cai, PhD2*, Xiaomei Yan, MD, PhD2*, Gang Huang, PhD1,2 and Yi Zheng, PhD1,2

1Cancer Biology Program, University of Cincinnati, Cincinnati, OH
2Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Avik Dutta, PhD, Yue Yang, PhD, Bao Le* and Golam Mohi, PhD

Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA

Na Yoon Paik1*, Grace E. Brown2*, Lijian Shao, MD, PhD3*, Kilian Sottoriva4*, James Hyun4*, Salman R. Khetani, PhD5* and Kostandin V. Pajcini, PhD4

1Department of Pharmacology, University of Illinois at Chicago, Chicago, IL
2Department of Bioengineering, University of Illinois at Chicago, Chicago, IL
3Department of Pharmacology, University of Illinois At Chicago, Chicago, IL
4Pharmacology, University of Illinois at Chicago, Chicago, IL
5Bioengineering, University of Illinois at Chicago, Chicago

Rasoul Pourebrahim, MD, PhD1*, Rafael Heinz Montoya, BS1*, Zoe Alaniz, BS1*, Lauren B Ostermann, BS1*, Edward Ayoub, PhD, MS, BSc1*, Patrick P Lin, MD2*, Jared K. Burks, PhD1* and Michael Andreeff, MD, PhD1

1Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Lijian Shao, MD, PhD1*, Na Yoon Paik2* and Kostandin V. Pajcini, PhD3

1Department of Pharmacology, University of Illinois At Chicago, Chicago, IL
2Department of Pharmacology, University of Illinois at Chicago, Chicago, IL
3Pharmacology, University of Illinois at Chicago, Chicago, IL

*signifies non-member of ASH